1-3 of 3
Nisha Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30 + lymphomas: results of a phase 1 trial

Clinical Trials & Observations
Jennifer N. Brudno, Danielle A. Natrakul, Jeremiah Karrs, Nisha Patel, Roberto Maass-Moreno, Mark A. Ahlman, Lekha Mikkilineni, Jennifer Mann, David F. Stroncek, Steven L. Highfill, Genevieve C. Fromm, Rashmika Patel, Stefania Pittaluga, James N. Kochenderfer
Journal: Blood Advances
Blood Adv (2024) 8 (3): 802–814.
https://doi.org/10.1182/bloodadvances.2023011470
Published: 2024
Includes: Supplemental data
Journal Articles

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

Clinical Trials & Observations
Ifeyinwa Emmanuela Obiorah, Bhavisha A. Patel, Emma M. Groarke, Weixin Wang, Megan Trick, Amanda K. Ombrello, Marcela A. Ferrada, Zhijie Wu, Fernanda Gutierrez-Rodrigues, Jennifer Lotter, Lorena Wilson, Patrycja Hoffmann, Daniela Ospina Cardona, Nisha Patel, Alina Dulau-Florea, Daniel L. Kastner, Peter C. Grayson, David B. Beck, Neal S. Young, Katherine R. Calvo
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3203–3215.
https://doi.org/10.1182/bloodadvances.2021004976
Published: 2021
Includes: Supplemental data
Journal Articles

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction

Clinical Trials & Observations
Claudia Hanni, Elizabeth Petrovitch, Mona Ali, Whitney Gibson, Christopher Giuliano, Jenna Holzhausen, Charles Makowski, Amy Pallisco, Nisha Patel, Denise Sutter, Long To, Raymond Yost
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2366–2371.
https://doi.org/10.1182/bloodadvances.2019000972
Published: 2020